NuVasive 2Q18 Revenue +8.5% vs. 2Q17

NuVasive (NUVA) reported 2Q18 revenue of US $281.6MM, +8.5% vs. 2Q17, and 1H18 revenue of $542.1MM, +6.6% vs. 1H17.

ORTHOWORLD estimates for segment sales and growth follow.

Q18 
Q17 
$ Change 
% Change 

 Spine...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.

JV

Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.



Contact Us

0